MedTrace Logo

Prospective Study to Compare a Limited Versus Extended Pelvic Lymphadenectomy During Prostatectomy

NCT01555086 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2017-01-24

No results posted yet for this study

Summary

This study examines Limited versus extended pelvic lymphadenectomy.

Conditions

Interventions

PROCEDURE

Limited pelvic Lymphadenectomy

approximately 10-14 lymph nodes are removed

PROCEDURE

Extended pelvic Lymphadenectomy

approximately 20 lymph nodes are removed

Sponsors & Collaborators

  • Association of Urologic Oncology (AUO)

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2017-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01555086 on ClinicalTrials.gov